Quantcast
Home > Quotes > DRRX
DRRX

DURECT Corporation Common Stock (DRRX) Quote & Summary Data

$0.8502
*  
0.0399
4.48%
Get DRRX Alerts
*Delayed - data as of Nov. 19, 2018  -  Find a broker to begin trading DRRX now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    DRRX Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
Today's High / Low
$ 0.9451 / $ 0.85
Share Volume
299,982
50 Day Avg. Daily Volume
287,201
Previous Close
$ 0.8901
52 Week High / Low
$ 2.55 / $ 0.8425
Market Cap
137,783,172
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

Shares Traded

Share Volume:
299,982
50 Day Avg. Daily Volume:
287,201

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -0.06

Trading Range

The current last sale of $0.8502 is 0.91% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 0.9451 $ 2.55
 Low: $ 0.85 $ 0.8425

Company Description (as filed with the SEC)

We are a biopharmaceutical company with research and development programs broadly falling into two categories: (i) new chemical entities derived from our Epigenetic Regulator Program, in which we attempt to discover and develop molecules which have not previously been approved and marketed as therapeutics, and (ii) Drug Delivery Programs, in which we apply our formulation expertise and technologies largely to active pharmaceutical ingredients whose safety and efficacy have previously been established but which we aim to improve in some manner through a new formulation. We also manufacture and sell osmotic pumps used in laboratory research and design, develop and manufacture a wide range of standard and custom biodegradable polymers and excipients for pharmaceutical and medical device clients for use as raw materials in their products. Our product pipeline currently consists of multiple investigational drug candidates in clinical development.  ... More ...  


Risk Grade

Where does DRRX fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 0.90
Open Date:
Nov. 19, 2018
Close Price:
$ 0.8502
Close Date:
Nov. 19, 2018

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x